MP
MapLight Therapeutics, Inc.
MPLT · NASDAQ
$10.92 -2.59% (-$0.29)
1M -3.87%
Market Cap $463.4M
P/E Ratio -
Div. Yield -
ROE 63.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.33x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 180.05%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 69.35%
Asset turnover 0.00x
ROE 63.84%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 16.52x
Int. coverage N/A
Stability
30 /100
Unstable Beta 2.57x
Profitable years 0
EPS volatility 30.04%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MPLT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher A. Kroeger
Employees
133
Headquarters
Redwood City
Nadcházející události
03 PRO
Earnings
Upcoming earnings report